210 related articles for article (PubMed ID: 12126604)
1. Cardiac Transplantation: Pre-transplant Infectious Diseases Evaluation and Post-transplant Prophylaxis.
Keay S
Curr Infect Dis Rep; 2002 Aug; 4(4):285-292. PubMed ID: 12126604
[TBL] [Abstract][Full Text] [Related]
2. Infectious complications of human bone marrow transplantation.
Winston DJ; Gale RP; Meyer DV; Young LS
Medicine (Baltimore); 1979 Jan; 58(1):1-31. PubMed ID: 368507
[TBL] [Abstract][Full Text] [Related]
3. Long-term results of CMV hyperimmune globulin prophylaxis in 377 heart transplant recipients.
Kocher AA; Bonaros N; Dunkler D; Ehrlich M; Schlechta B; Zweytick B; Grimm M; Zuckermann A; Wolner E; Laufer G
J Heart Lung Transplant; 2003 Mar; 22(3):250-7. PubMed ID: 12633691
[TBL] [Abstract][Full Text] [Related]
4. Infectious complications in renal transplant recipients.
Parasuraman R; Yee J; Karthikeyan V; del Busto R
Adv Chronic Kidney Dis; 2006 Jul; 13(3):280-94. PubMed ID: 16815233
[TBL] [Abstract][Full Text] [Related]
5. Viral prophylaxis in organ transplant patients.
Slifkin M; Doron S; Snydman DR
Drugs; 2004; 64(24):2763-92. PubMed ID: 15563248
[TBL] [Abstract][Full Text] [Related]
6. Review of Infectious Disease Prophylaxis in Solid Organ Transplantation.
Personett HA; Laub MR
Crit Care Nurs Q; 2017; 40(4):383-398. PubMed ID: 28834860
[TBL] [Abstract][Full Text] [Related]
7. Provision of laboratory services for heart and lung transplantation in Australia.
Schneider HG; Rutherford D; Kotsimbos T
Clin Chim Acta; 2001 Nov; 313(1-2):221-9. PubMed ID: 11694263
[TBL] [Abstract][Full Text] [Related]
8. Cytomegalovirus infection and cardiac allograft vasculopathy.
Koskinen PK; Kallio EA; Tikkanen JM; Sihvola RK; Häyry PJ; Lemström KB
Transpl Infect Dis; 1999 Jun; 1(2):115-26. PubMed ID: 11428979
[TBL] [Abstract][Full Text] [Related]
9. Ganciclovir: an update of its use in the prevention of cytomegalovirus infection and disease in transplant recipients.
McGavin JK; Goa KL
Drugs; 2001; 61(8):1153-83. PubMed ID: 11465876
[TBL] [Abstract][Full Text] [Related]
10. EPICO 3.0. Antifungal prophylaxis in solid organ transplant recipients.
Zaragoza R; Aguado JM; Ferrer R; Rodríguez AH; Maseda E; Llinares P; Grau S; Muñoz P; Fortún J; Bouzada M; Pozo JC; León R;
Rev Iberoam Micol; 2016; 33(4):187-195. PubMed ID: 27067875
[TBL] [Abstract][Full Text] [Related]
11. The use of contaminated donor organs in transplantation.
Zibari GB; Lipka J; Zizzi H; Abreo KD; Jacobbi L; McDonald JC
Clin Transplant; 2000 Aug; 14(4 Pt 2):397-400. PubMed ID: 10946778
[TBL] [Abstract][Full Text] [Related]
12. Muromonab CD3: a reappraisal of its pharmacology and use as prophylaxis of solid organ transplant rejection.
Wilde MI; Goa KL
Drugs; 1996 May; 51(5):865-94. PubMed ID: 8861551
[TBL] [Abstract][Full Text] [Related]
13. Non-immunological complications following kidney transplantation.
Cohen-Bucay A; Gordon CE; Francis JM
F1000Res; 2019; 8():. PubMed ID: 30828430
[TBL] [Abstract][Full Text] [Related]
14. Infectious complications in indigenous renal transplant recipients in Western Australia.
Boan P; Swaminathan R; Irish A
Intern Med J; 2017 Jun; 47(6):648-655. PubMed ID: 28370833
[TBL] [Abstract][Full Text] [Related]
15. Cytomegalovirus viraemia and mortality in renal transplant recipients in the era of antiviral prophylaxis. Lessons from the western Australian experience.
Selvey LA; Lim WH; Boan P; Swaminathan R; Slimings C; Harrison AE; Chakera A
BMC Infect Dis; 2017 Jul; 17(1):501. PubMed ID: 28716027
[TBL] [Abstract][Full Text] [Related]
16. Vaccination practices in End Stage Renal Failure and Renal Transplantation; Review of current guidelines and recommendations.
Gunawansa N; Rathore R; Sharma A; Halawa A
World J Transplant; 2018 Jun; 8(3):68-74. PubMed ID: 29988933
[TBL] [Abstract][Full Text] [Related]
17. Outcomes in cardiac transplant recipients using allografts from older donors versus mortality on the transplant waiting list; Implications for donor selection criteria.
Lietz K; John R; Mancini DM; Edwards NM
J Am Coll Cardiol; 2004 May; 43(9):1553-61. PubMed ID: 15120811
[TBL] [Abstract][Full Text] [Related]
18. Recent Advances in Mammalian Target of Rapamycin Inhibitor Use in Heart and Lung Transplantation.
Fine NM; Kushwaha SS
Transplantation; 2016 Dec; 100(12):2558-2568. PubMed ID: 27495747
[TBL] [Abstract][Full Text] [Related]
19. Common infections in kidney transplant recipients.
Karuthu S; Blumberg EA
Clin J Am Soc Nephrol; 2012 Dec; 7(12):2058-70. PubMed ID: 22977217
[TBL] [Abstract][Full Text] [Related]
20. Unrecognized pre-transplant disseminated Coxiella burnetti infection diagnosed in a post-transplant heart-kidney recipient.
Jandhyala D; Farid S; Mahmood M; Deziel P; Abu Saleh O; Raoult D; Beam E
Transpl Infect Dis; 2018 Oct; 20(5):e12962. PubMed ID: 29975810
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
